Cetera Investment Advisers’s Core Scientific CORZ Stock Holding History

Cetera Investment Advisers’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630K	Buy	24,610 +11,379	+86%	+$268K	﹤0.01%	3479
2026 Q1	$198K	Buy	+13,231	New	+$226K	﹤0.01%	4292
2025 Q4	–	Sell	-15,455	Closed	-$277K	–	4730
2025 Q3	$277K	Sell	15,455 -23,364	-60%	-$343K	﹤0.01%	3897
2025 Q2	$663K	Buy	38,819 +25,878	+200%	+$259K	﹤0.01%	2739
2025 Q1	$93.7K	Sell	12,941 -5,466	-30%	-$62.2K	﹤0.01%	3787
2024 Q4	$259K	Sell	18,407 -56,974	-76%	-$842K	﹤0.01%	3221
2024 Q3	$894K	Buy	+75,381	New	+$781K	﹤0.01%	2201

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Cetera Investment Advisers's CORZ Position: Q2 2026 in Review

Cetera Investment Advisers increased its Core Scientific (CORZ) stake by 86% in Q2 2026, buying an estimated $268K and bringing the position to 24,610 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #3479.

Cetera Investment Advisers first reported a position in CORZ in Q3 2024 and has held it in 7 quarters since. The position peaked at $894K in Q3 2024. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Cetera Investment Advisers held 24,610 shares of Core Scientific worth $630K as of Q2 2026.
Cetera Investment Advisers bought 11,379 Core Scientific shares in Q2 2026, an estimated $268K.
Core Scientific made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3479 holding.
Cetera Investment Advisers first reported a position in Core Scientific in Q3 2024 and has held it in 7 quarters since.
Cetera Investment Advisers's Core Scientific position peaked at $894K in Q3 2024.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.